Browsing: England

Pharming’s Joenja, a treatment for APDS, has been approved for reimbursement in England after NICE reversed its earlier rejection. The EU regulatory review is still ongoing.

A former senior figure at England’s NICE states that advanced therapies for common conditions would not qualify for the usual payment modifiers.